home / stock / icpt / icpt articles

ICPT Articles, Intercept Pharmaceuticals Inc. - From 09/27/23

Stock Information
Company Name: Intercept Pharmaceuticals Inc.
Stock Symbol: ICPT
Market: NASDAQ
Website: interceptpharma.com
Menu
ICPT ICPT Quote ICPT Short ICPT News ICPT Articles ICPT Message Board
Get ICPT Alerts

News, Short Squeeze, Breakout and More Instantly...
ICPT STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of Intercept Pharmaceuticals, Inc. Is Fair to Shareholders | Benzinga

NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Intercept Pharm...
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withd...

ICPT Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Intercept Pharmaceuticals to Alfasigma | Benzinga

MONSEY, N.Y., Sept. 26, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of I...

Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday | Benzinga

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s sessio...
Dow Tumbles 150 Points; US House Prices Rise in July | Benzinga

U.S. stocks traded lower this morning, with the Dow Jones falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow trade...

Why Is Rare Liver Disease Focused Intercept Pharmaceuticals Stock Trading Higher Today? | Benzinga

Italy-based Alfasigma has agreed to acquire Intercept Pharmaceuticals Inc (NASDAQ: ICPT) for $19.00 per share in cash.&nbs...

Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session | Benzinga

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the...
Investors Eye CymaBay's AFFIRM Study As Regulatory Uncertainties Ease | Benzinga

Thursday, CymaBay Therapeutics Inc (NASDAQ: CBAY) initiated the AFFIRM Phase 3b/4 confirmatory study to evaluate the effect of seladelpar...

Previous 10 Next 10